Literature DB >> 2393407

The gene for human acidic fibroblast growth factor encodes two upstream exons alternatively spliced to the first coding exon.

G Crumley1, C A Dionne, M Jaye.   

Abstract

We have isolated two cDNA clones encoding human acidic fibroblast growth factor (aFGF) which represent the utilization of alternative upstream exons in aFGF mRNA. Isolation and sequence analysis of genomic clones spanning the first coding exon and each of the upstream sequences confirms that the divergent 5' sequences are separate exons, spliced alternatively to the first coding exon 34 nucleotides upstream of the initiator AUG codon. Restriction mapping of the genomic clones provides a minimum size estimate of 45 kilobase pairs for the aFGF locus.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2393407     DOI: 10.1016/0006-291x(90)91348-v

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  6 in total

1.  New nucleotide sequence data on the EMBL File Server.

Authors: 
Journal:  Nucleic Acids Res       Date:  1991-06-25       Impact factor: 16.971

2.  A sequence tagged site (STS) detects EcoRI polymorphisms in the human acidic fibroblast growth factor gene.

Authors:  W P Wang; I M Chiu
Journal:  Nucleic Acids Res       Date:  1991-08-25       Impact factor: 16.971

Review 3.  An analysis of vertebrate mRNA sequences: intimations of translational control.

Authors:  M Kozak
Journal:  J Cell Biol       Date:  1991-11       Impact factor: 10.539

4.  An STS in a 5' untranslated exon of the human acidic fibroblast growth factor (aFGF) gene.

Authors:  R A Payson; W P Wang; H Canatan; I M Chiu
Journal:  Nucleic Acids Res       Date:  1991-12-11       Impact factor: 16.971

5.  Human dermal fibroblasts express multiple bFGF and aFGF proteins.

Authors:  L L Root; G D Shipley
Journal:  In Vitro Cell Dev Biol       Date:  1991-10

6.  An acidic fibroblast growth factor protein generated by alternate splicing acts like an antagonist.

Authors:  Y L Yu; H Kha; J A Golden; A A Migchielsen; E J Goetzl; C W Turck
Journal:  J Exp Med       Date:  1992-04-01       Impact factor: 14.307

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.